Cover Image

中樞神經系統 (CNS) 淋巴瘤的全球市場:預後的種類·診斷的種類·治療的種類·各用途的未來預測

CNS Lymphoma Market: By Prognosis Type (Immunocompetent, AIDS); By Diagnosis Type (Lumbar Puncture, MRI, CT, CBC); By Types of Treatments (Radiation Therapy, Chemotherapy, Steroid Therapy, Targeted Therapy); By Geography - (2016-2022)

出版商 IndustryARC 商品編碼 416591
出版日期 內容資訊 英文 153 Pages
商品交期: 最快1-2個工作天內
Back to Top
中樞神經系統 (CNS) 淋巴瘤的全球市場:預後的種類·診斷的種類·治療的種類·各用途的未來預測 CNS Lymphoma Market: By Prognosis Type (Immunocompetent, AIDS); By Diagnosis Type (Lumbar Puncture, MRI, CT, CBC); By Types of Treatments (Radiation Therapy, Chemotherapy, Steroid Therapy, Targeted Therapy); By Geography - (2016-2022)
出版日期: 2017年09月04日 內容資訊: 英文 153 Pages

本報告提供全球中樞神經系統 (CNS) 淋巴瘤的市場相關分析,提供整體市場結構和背景情況,主要的推動及阻礙市場要素,預後/診斷/治療類別及地區別的市場趨勢預測,市場競爭情勢,近來的資本交易·策略發展的動向,主要企業的簡介等相關調查。

第1章 市場概要

第2章 摘要整理

第3章 中樞神經系統 (CNS) 淋巴瘤市場:市場環境

  • 市場佔有率分析
  • 競爭分析
    • 終端用戶的簡介
    • 專利分析
    • 前五名公司的財務分析

第4章 CNS淋巴瘤市場:對市場的影響要素

  • 市場成長促進因素
  • 阻礙市場要素
  • 市場課題
  • 市場向心力:波特的五力分析

第5章 CNS淋巴瘤市場:策略分析

  • 價值鏈分析
  • 價格趨勢分析
  • 市場機會分析
  • 產品生命週期分析
  • 供應商/經銷商

第6章 CNS淋巴瘤市場:預後類別

  • 免疫響應能力
  • AIDS (後天性免疫機能喪失症候群)

第7章 CNS淋巴瘤市場:診斷類別

  • 腰椎穿刺/腦脊髓液 (CSF)的病理分析
  • 腦切片檢查樣品採取
  • MRI (核磁共振成像)
  • CT (電腦斷層攝影) 掃描
  • 定位切片檢查
  • 血液常規檢查 (CBC)
  • 其他

第8章 CNS淋巴瘤市場:治療類別

  • 放射治療
  • 化療
  • 類固醇治療
  • 大量化療 (附幹細胞移植)
  • 標靶治療
  • 其他

第9章 CNS淋巴瘤市場:各地區

  • 北美 (美國,加拿大等)
  • 歐洲 (英國,德國,法國,西班牙,義大利等)
  • 亞太地區 (中國,印度,日本,澳洲等)
  • 南美 (巴西,阿根廷,墨西哥等)
  • 其他的國家 (RoW:中東,非洲)

第10章 CNS淋巴瘤市場:市場熵 (市場變化的方向性)

  • 新產品的銷售
  • 企業合併·收購 (M&A),事業聯盟·合作,合資企業 (JV)

第11章 企業簡介 (概要,財務分析,主要產品與服務,近幾年趨勢,競爭企業,客戶)

  • Brainstrust
  • Brain and Spine Foundation
  • Headway
  • Royal National Institute for the Blind (RNIB)
  • Carers UK
  • Cancer Research UK
  • American Brain Tumor Association
  • Leukaemia Foundation
  • Macmillan Cancer Support
  • Center for Lymphoid Malignancies

第12章 附錄



Central Nervous System (CNS) Lymphoma or microglioma is a disease in which cancer cells are formed in the lymph tissue of brain or spinal cord. This is observed primarily in the patients with very weak immune systems, patients suffering from immonosuppression and AIDS patients. Moreover, this disorder may affect eyes as well called as ocular lymphoma. Patients recently having kidney or other organ transplant are also at a high risk of having CNS lymphoma due to their low count of T-Cells or low level of immunity. The major symptoms of this disease majorly depend on the area affected. However, the major symptoms include headaches, memory problem, drowsiness, seizures, nausea, vomiting, personality changes, throat infection, body weakness and sometimes even hearing loss and double vision. This disease may occur in all age groups; however, mostly noticed in 50+ age group.

There are several diagnosis methods to detect CNS lymphoma; however, treatments are subjected to several clinical trials. The report covers the major diagnosis methods including lumber puncture, pathological analysis of Cerebro-Spinal Fluid (CSF), brain biopsy sampling, Magnetic Resonanace Imaging (MRI), Computed Topography (CT) scan, stereostatic biopsy, and complete blood count. Among all these, MRI scan is most widely used diagnosis method and accounts for larger percent share in the diagnosis market of CNS lymphoma. At later stage of the disease, brain biopsy, tissue biopsy, and spinal tap are the most important tests to make a definite diagnosis. Diagnosis of CNS lymphoma at early stage is difficult and can often be delayed by doctors as well as patients.

CNS Lymphoma Market

The report highlights the prime factors impacting the growth of CNS lymphoma detection and treatment market with detailed analysis on drivers, restraints, and opportunities in the market. The major causes of the disease, its prognosis, and diagnosis are deeply analyzes and their granular level analysis is provided in the report. The report covers various treatments used for nowadays for treating CNS lymphoma. Some of these include radiation therapy, chemotherapy, high dose chemotherapy with stem cell transplant, and targeted therapy. Radiation therapy is considered most successful amongst all; however, is associated with several other complications due to repetitive radiation exposure. Chemotherapy involves usage of high dosage of drugs which may result in to other several side effects. Previously, there were very poor chances of life expectancy for a person suffering from CNS lymphoma; however, due to high technological advantages and types of available treatments these days, the life expectancy is prolonged and patients have opportunity of recovery.

The report offers in depth regional analysis of CNS lymphoma treatment and diagnosis market. The major regions covered in the report include North America, Europe, Asia-Pacific, and Latin America. The geographies with high market revenue are analyzed and the developments are exhaustively tracked for these regions. Among all the regions, Europe is estimated to have high investments in research & development of the treatments and drugs for CNS lymphoma. There is lacks disease awareness among the people in most of the countries in Asia-Pacific region but is expected to have high potential growth for the diagnosis and treatment of CNS lymphoma in next 5 years.

The report gives detailed insights on the competitiveness of the market. The report tracks the key business strategies and developments adopted by the key vendors in this market. Market share analysis of these vendors is also provided under the market entropy section.

Some of the major research centers for the CNS lymphoma include:


Brain & spine Foundation


Royal National Institute for Blind (RNIB)

Carers UK

Macmillan Cancer Support

1. Market Overview

2. Executive Summary

3. CNS Lymphoma Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
    • 3.2.1. End-User Profiling
    • 3.2.2. Patent Analysis
    • 3.2.3. Financial Analysis of Top 5 Players

4. CNS Lymphoma Market Forces

  • 4.1. Market Drivers
  • 4.2. Market Constraints
  • 4.3. Market Challenges
  • 4.4. Attractiveness of Industry
    • 4.4.1. Power of Supplier
    • 4.4.2. Power of Consumer
    • 4.4.3. Threat of New Entrants
    • 4.4.4. Threat of Substitution
    • 4.4.5. Degree of Competition

5. CNS Lymphoma Market-Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunity Analysis
  • 5.4. Product Life Cycle Analysis
  • 5.5. Suppliers & Distributors

6. CNS Lymphoma Market- By Prognosis Type

  • 6.1. Immunocompetent
  • 6.2. AIDS

7. CNS Lymphoma Market- By Type of Diagnosis

  • 7.1. Lumbar Puncture/Pathological Analysis of cerebrospinal fluid (CSF)
  • 7.2. Brain biopsy sampling
  • 7.3. MRI (magnetic resonance imaging)
  • 7.4. CT (computed topograph)Scan
  • 7.5. Stereotactic Biopsy
  • 7.6. Complete Blood Count
  • 7.7. Others

8. CNS Lymphoma Market Market- By Types of Treatments

  • 8.1. Radiation Therapy
  • 8.2. Chemotherapy
  • 8.3. Steroid Therapy
  • 8.4. High-dose chemotherapy with stem cell transplant
  • 8.5. Targeted Therapy
  • 8.6. Others

9. Clinical Information System Market- By Geography

  • 9.1. North America
    • 9.1.1. The U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. The U.K.
    • 9.2.2. Germany
    • 9.2.3. France
    • 9.2.4. Spain
    • 9.2.5. Italy
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. India
    • 9.3.3. Japan
    • 9.3.4. Australia
    • 9.3.5. Rest of APAC
  • 9.4. Latin America
    • 9.4.1. Brazil
    • 9.4.2. Argentina
    • 9.4.3. Mexico
    • 9.4.4. Rest of Latin America
  • 9.5. Rest of the World
    • 9.5.1. The Middle East
    • 9.5.2. Africa

10. CNS Lymphoma Market Entropy

  • 10.1. New Product Launches
  • 10.2. M&As, Collaborations, Partnerships & JVs

11. Company Profiles (Overview, Financials, Products & Services, Recent Developments, Competitors & Customers)

  • 11.1. Brainstrust
  • 11.2. Brain and Spine Foundation
  • 11.3. Headway
  • 11.4. Royal National Institute for the Blind (RNIB)
  • 11.5. Carers UK
  • 11.6. Cancer Research UK
  • 11.7. American Brain Tumor Association
  • 11.8. Leukaemia Foundation
  • 11.9. Macmillan Cancer Support
  • 11.10. Center for Lymphoid Malignancies

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Sources
  • 12.3. Research Methodology
  • 12.4. Bibliography
  • 12.5. Compilation of Expert Insights
Back to Top